Literature DB >> 10699993

Multiple 'serrated adenocarcinomas' of the colon with a cell lineage common to metaplastic polyp and serrated adenoma. Case report of a new subtype of colonic adenocarcinoma with gastric differentiation.

T Yao1, K i Nishiyama, M Oya, T Kouzuki, M Kajiwara, M Tsuneyoshi.   

Abstract

A 70-year-old woman underwent right hemicolectomy and six carcinomas were recognized in the resected colon. These carcinomas were considered to be of a cell lineage common to serrated adenoma (SA) and hyperplastic (metaplastic) polyp (H/MP), because of the occurrence of multiple SAs and H/MPs around the carcinomas, as well as the co-existence of SA and H/MP areas within the carcinomas. These carcinomas had the following common histological and immunohistochemical features: a serrated structure resembling SA; a lace-like structure; infiltrative growth within the muscularis propria, with dedifferentiation at the invasive front; and immunohistochemical expression of pS2 and human gastric mucin. Based on these features, a new subtype of carcinoma is proposed, with a cell lineage common to SA and H/MP. It would also seem that p53 is involved in the serrated adenoma-carcinoma sequence. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699993     DOI: 10.1002/(SICI)1096-9896(200003)190:4<444::AID-PATH520>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Hierarchical clustering identifies a subgroup of colonic adenocarcinomas expressing crypt-like differentiation markers, associated with MSS status and better prognosis.

Authors:  Laure Droy-Dupré; Céline Bossard; Christelle Volteau; Stéphane Bezieau; Christian L Laboisse; Jean-François Mosnier
Journal:  Virchows Arch       Date:  2015-02-11       Impact factor: 4.064

2.  Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.

Authors:  Natsuko Tatsumi; Ken-Ichi Mukaisho; Shoji Mitsufuji; Yoichi Tatsumi; Hiroyuki Sugihara; Takeshi Okanoue; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

3.  A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.

Authors:  Karam S Boparai; Evelien Dekker; Mirjam M Polak; Alex R Musler; Susanne van Eeden; Carel J M van Noesel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

4.  Frequent CpG island methylation in serrated adenomas of the colorectum.

Authors:  Seun-Ja Park; Asif Rashid; Jae-Hyuk Lee; Sang Geol Kim; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 5.  [Serrated pathway of colorectal carcinogenesis].

Authors:  G B Baretton
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

6.  [Development of molecular-pathologic entities of colorectal cancer].

Authors:  T Kirchner; S Reu
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 7.  Gastric hyperplastic polyps: a review.

Authors:  Richa Jain; Runjan Chetty
Journal:  Dig Dis Sci       Date:  2008-11-27       Impact factor: 3.199

8.  Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.

Authors:  P Minoo; K Baker; R Goswami; G Chong; W D Foulkes; A R Ruszkiewicz; M Barker; D Buchanan; J Young; J R Jass
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

9.  Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps.

Authors:  Nimet Dayi; Hideo A Baba; Kurt W Schmid; Klaus J Schmitz
Journal:  Diagn Pathol       Date:  2013-10-23       Impact factor: 2.644

10.  Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma.

Authors:  Daiki Hirano; Shiro Oka; Shinji Tanaka; Kyoku Sumimoto; Yuki Ninomiya; Yuzuru Tamaru; Kenjiro Shigita; Nana Hayashi; Yuji Urabe; Yasuhiko Kitadai; Fumio Shimamoto; Koji Arihiro; Kazuaki Chayama
Journal:  BMC Gastroenterol       Date:  2017-12-12       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.